The NISO Open Discovery Initiative: promoting transparency in discovery

Promoting Antibiotic Discovery and Development a California Healthcare Institute Initiative

A brief history of the Open Discovery Initiative

The NISO Open Discovery Initiative (ODI) was born at the American Library Association (ALA) Annual Conference in 2011 with a straightforward aspiration: to foster transparency across the participants in the then-novel arena of web-scale discovery tools. While these discovery services – Primo Central, Summon, EBSCO Discovery Service, Google Scholar, and their like – are now commonplace, they wer...

The Discovery of Islamic Ethics in Organizational Silence

Organizational silence is one of the emerging issues in the field of ethics and organizational behavior management. Most of the existing writings, having thought its moral falsity as something established, have sought to analyze the causes and factors. The present paper, disagreeing the presupposition and being inspired by the "processional method of exploring Islamic theory", seeks to discover...

Promoting transparency, accountability, and access through a multi-stakeholder initiative: lessons from the medicines transparency alliance

BACKGROUND Barriers to expanding access to medicines include weak pharmaceutical sector governance, lack of transparency and accountability, inadequate attention to social services on the political agenda, and financing challenges. Multi-stakeholder initiatives such as the Medicines Transparency Alliance (MeTA) may help overcome these barriers. Between 2008 and 2015, MeTA engaged stakeholders i...

Open Drug Discovery Toolkit (ODDT): a new open-source player in the drug discovery field

BACKGROUND There has been huge progress in the open cheminformatics field in both methods and software development. Unfortunately, there has been little effort to unite those methods and software into one package. We here describe the Open Drug Discovery Toolkit (ODDT), which aims to fulfill the need for comprehensive and open source drug discovery software. RESULTS The Open Drug Discovery To...